These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2681514)

  • 1. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes.
    Edwards CQ; Griffen LM; Kaplan J; Kushner JP
    J Intern Med; 1989 Nov; 226(5):373-9. PubMed ID: 2681514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele.
    Milman N
    Eur J Haematol; 1991 Oct; 47(4):292-8. PubMed ID: 1954989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population.
    Merryweather-Clarke AT; Worwood M; Parkinson L; Mattock C; Pointon JJ; Shearman JD; Robson KJ
    Br J Haematol; 1998 May; 101(2):369-73. PubMed ID: 9609537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis.
    Beamish MR; Walker R; Miller F; Worwood M; Jacobs A; Williams R; Corrigall A
    Br J Haematol; 1974 Jun; 27(2):219-28. PubMed ID: 4843672
    [No Abstract]   [Full Text] [Related]  

  • 6. Transferrin behaviour in primary haemochromatosis.
    Cartei G; Causarano D; Naccarato R
    Experientia; 1975 Mar; 31(3):373-5. PubMed ID: 1116555
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of haemochromatosis gene mutations in the general population: implications for screening.
    Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA
    Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic iron clearance from serum in treated hemochromatosis.
    Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV
    Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families.
    Muir WA; McLaren GD; Braun W; Askari A
    Am J Med; 1984 May; 76(5):806-14. PubMed ID: 6720728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis.
    Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
    J Intern Med; 2012 Jan; 271(1):51-63. PubMed ID: 21605201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of 5 patients with possible primary hemochromatosis].
    Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status.
    Chow LH; Frei JV; Hodsman AB; Valberg LS
    Gastroenterology; 1985 Apr; 88(4):865-9. PubMed ID: 3838288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary haemochromatosis.
    Edwards CQ; Dadone MM; Skolnick MH; Kushner JP
    Clin Haematol; 1982 Jun; 11(2):411-35. PubMed ID: 7042159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.